Annual Drug Patent Expirations for OXBRYTA
Oxbryta is a drug marketed by Global Blood Theraps and is included in two NDAs. There are nine patents protecting this drug.
This drug has two hundred and thirty patent family members in thirty-seven countries.
The generic ingredient in OXBRYTA is voxelotor. Additional details are available on the voxelotor profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
